Exposure assessment is part of an overall risk analysis process used by governmental and industrial organizations to decide whether various activities associated with potentially hazardous materials pose a threat to human health or the environment. (Figure 1 ). Although exposure assessment relies on hazard identification, it must be coupled with additional information to characterize the hazard or risk in order to gain a perspective above the significance of the exposure. Uncertainties associated with current methodologies prevent the precise identification of specific environmental and individual exposures, as well as actual intake of substances and subsequent adverse health effects. Given the present state of knowledge about interspecies extrapolation of toxic effects, it appears that major reductions in the uncertainties associated with risk assessment that are likely to be achieved in the near future will be due to improvements in our ability to estimate exposure to chemicals.
This symposium reviewed the strength of techniques now available to estimate exposure and discussed what can be done in the future to improve assessment. The presentations in this symposium addressed three generic questions (Table 1) . What are we exposed to? (LaGrone and Wallace); How do we estimate exposure to body tissues? (Wogan, Weston et al., Dunn) ; and What is the link between exposure and disease? (Chapman et al. and Anton-Culver and Burg) .
The state of the art of exposure measurements and recommendations to improve the science and utility of exposure assessment were discussed. Several themes were identified, including the need to improve methodology, conduct basic research, collect health surveillance data, understand the effects of multiple exposures to pollutants, collaborate among scientific disciplines, and strengthen community education and community relations efforts concerning the public's exposure to chemicals.
IMPROVING THE METHODOLOGY
Exposure assessment methods can be organized into three categories: direct, predictive, or reconstructive. The direct method is based on actual measurement of the substances to which -Linking personal dosimetry with outcome in a well defined population-Chapman -Linking disease occurrence in general populations to environmental exposures using population based disease and exposure registeries-Anton-Culver and Burg an individual is exposed. The predictive approach uses measures of ambient exposure in air. water, and/or soil, as well as mathematical models to estimate individual exposures. The reconstructive approach uses measurements taken from the individual, such as body burden and biomarkers, to re-create the nature of the exposure. While significant progress has been made over the last decade in developing new methods to measure chemicals and their byproducts in the environment and biological media, many improvements need to be made in both test methods and mathematical models. Several areas were discussed during the symposium and are summarized below.
Detection techniques
Sampling and monitoring techniques need to be developed that will improve the detection of chemically unstable and reactive materials and volatile substances. Macromolecular adduct techniques and internal dosimeters need to be developed for more categories of chemical substances than it is now possible to detect. Biomarkers and pharmacokinetic measures need to be identified and characterized with respect to chemical exposure, transformation, and fate within the body, and linked to effects within the body.
Validation
Assays to measure tissue exposure (e.g., adduct formation) may rely on biological manipulations that are difficult to control. Under these circumstances, two independent corroborative analyses need to be developed for each substance or category of substances for use in exposure assessment studies. Validation studies should be designed to provide quantitative estimates of residual uncertainties associated with the exposure estimates. Furthermore, and perhaps more important, validation of any exposure assessment method depends on demonstrable evidence that the procedure in question accurately characterizes the ultimate adverse health risk. Macromolecular adduct formation techniques are currently being validated for this purpose.
Protocol development and source apportionment
The objective of exposure assessment is to provide an accurate estimation of chemical exposures. To facilitate this, we need to measure the presence of substances from many chemical classes and account for exposures from several environmental media over time. Background levels of chemical substances, individual and species-specific differences in metabo-FOWLE lism, and dietary and personal lifestyle choices, as well as occupation, geographic location, and other variables may affect exposure patterns and the ultimate internal target tissue dose.
Improving the assimilation of the myriad factors that influence exposure estimates may be facilitated by combining the direct, reconstructive, and predictive exposure assessment techniques whenever possible. Such multidirectional approaches are needed to improve exposure measurements, validate techniques, and generate data for the development and refinement of mathematical models that will allow data collected under a variety of monitoring conditions to be combined for predictive assessment.
THE NEED FOR BASIC RESEARCH
Basic research is crucial for reducing the uncertainties inherent in exposure assessment. Knowledge of absorption for a wide variety of chemicals across the lungs, skin, and digestive tract is fundamental to relating environmental exposures to internal dose. In addition, knowledge of disease mechanisms, metabolic processes, and distribution of chemicals throughout the body can significantly reduce the uncertainties inherent in current risk assessment models. Studies of these parameters through parallel experimentation in humans and other species are important for several reasons. First, they would provide a better basis for extrapolation between species and exposure levels. Second, by including molecular epidemiologic and clinical data, they could contribute to the development of tools to improve exposure assessment through examination and correlation of the total exposure individuals experience. Third, they could be used to categorize susceptibility and interindividual variation in relation to metabolic and pharmacodynamic parameters. Fourth, they could identify background levels of substances and ascertain their contribution to total exposures. For instance, as noted at the symposium by Dr.
Wogan, much basic research needs to be done to characterize target tissue dosimetry, persistence, and the biological significance of protein and DNA adduct levels, and more research should be undertaken on background exposures, as noted by Dr. Wallace in his presentation on the total exposure assessment methodology.
COLLECTION OF HEALTH SURVEILLANCE DATA
The collection of health surveillance data is vital to determining the associations between adverse health effects and chemical exposures of concern. Health surveillance can be conducted in various ways, such as the development of registries for cancer, birth defects, and adverse reproductive effects. Environmental monitoring data bases also need to be established, and perhaps human exposure data bases as well, to allow us to understand better causal relationships.
EFFECTS OF MULTIPLE EXPOSURE TO POLLUTANTS
Although humans are exposed to a multitude of pollutants in complex mixtures, it is not possible to study the potential health effects of all possible chemical interactions on humans or in animal models. It may be expected that responses to exposure to mixtures include antagonistic effects, synergistic effects, and sensitization to future exposures. Work is needed to identify major categories of chemical exposures from the environment, diet, and other personal activities and to evaluate their effects on susceptibility to exposures (increasing or decreasing uptake or adverse effect, altering metabolism, etc.).
COLLABORATION AMONG SCIENTIFIC DISCIPLINES
One theme woven through all the presentations was the need for collaboration between scientists, governmental agencies, and the industrial sector for effective exposure assessment. Environmental problems are complex and require expertise across many scientific disciplines. Exposure assessment requires skills ranging from atmospheric, aquatic, and soil sciences through analytical chemistry, molecular biology, toxicology, and epidemiology. The problems are multifaceted scientifically and collaborative efforts are essential for effective understanding.
Appropriate epidemiologic design needs to be coupled with chemical analysis to link outcome with exposure. In particular, it was noted that the future trend will be to link longitudinal cohort studies with exposure measures through exposure registries, for instance, as under the federal Agency for Toxic Substances and Disease Registry (ATSDR) or, at the state level, the Orange County, California, cancer registry.
Utilization of the mandates of various laws through interagency work efforts should be encouraged and supported. An example of collaboration was given between ATSDR, the Environmental Protection Agency (EPA), and the National Toxicology Program (NTP) in the context of the 1986 reauthorization of the Superfund Amendments and Reauthorization Act of 1986 (SARA). SARA requires that EPA and ATSDR rank certain pollutants in priority order and requires ATSDR to write a toxicologic profile identifying data gaps and research needs. ATSDR is then required to initiate a research program to fill those gaps in cooperation with the NTP and EPA, using whenever possible the provisions of the Toxic Substances Control Act (TSCA) and the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA).
One suggestion from this meeting was to establish a multiagency effort to develop a coordinated exchange of information and work efforts to improve exposure assessment.
STRENGTHENING COMMUNITY EDUCATION AND COMMUNITY RELATIONS
Federal laws require that major environmental decisions be made within certain time frames. These decisions are sometimes made even when good scientific information is lacking and there are varying degrees of scientific certainty. They often arouse great controversy. More needs to be done to differentiate significant from trivial risks, to communicate these to affected parties (i.e., Congress, industry, general public), and to concentrate on the significant problems. A recent report by EPA Unfinished Business: A Comparative Assessment of Environmental Problems (Washington, D.C.: USEPA, Office of Policy Analysis, Office of Planning, Policy and Evaluation, 1987) ranked regulatory efforts with respect to risk. In some cases, inordinate amounts of time and effort are thought by EPA to be spent on lower-priority areas. How do we improve the establishment priorities and focus on the important problems? The symposium presentation by Dr. Wallace suggested we are misdirecting our emphasis through our regulatory efforts on outdoor rather than indoor air. Is this true, and if so, what does that mean about establishing our priorities for health risks?
Much of the discussion at the end of the symposium raised issues that have more bearing on risk perception than on the scientific issues. How do you communicate risk or exposure assessment studies? It was suggested that more time spent with community members would more likely result in studies that reflect community concerns and that the results would be communicated more effectively.
SUMMARY AND PERSPECTIVE
Exposure evaluation is an integral component of the risk assessment process linking chemical contact to toxicologic manifestation or disease outcome. When exposure data are used to make FOWLE decisions in the absence of corroborating data or disease outcome, human risk assessments rely on conservative assumptions that may overestimate true risk. A major theme of the symposium was that conservative assumptions in risk assessment could be replaced and uncertainties reduced as data on exposure assessment are coupled with health effect outcomes. Many of the uncertainties associated with exposure assessment are the result of a lack of measurement techniques, lack of understanding of differences in human susceptibility, interindividual variation, and differences in absorption, fate, transformation, and disease processes. Basic research and collaborative studies are needed to develop techniques, models, and data to reduce these uncertainties. Other important themes that emerged from the symposium are that social issues are as important as scientific issues in conducting effective exposure assessments, and that decisions will be made regardless of data availability or quality. To increase the effectiveness of exposure assessment studies, affected communities need to be involved early and often.
